Buy Jounce Therapeutics Stock | JNCE Stock Price & Latest News | Public
JNCE

Jounce Therapeutics

$0.00 (0.00%)Today
    Small Market Cap

    About JNCE

    Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which treat cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. Its products pipeline include JTX-2011 (ICOS); JTX-4014 (PD-1); ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.27
    -0.55
    -0.82
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.78

    Actual EPS
    Q3 2020

    Stats

    Market Cap$337,01M
    Volume44,93k
    Price-to-Earnings Ratio15.99
    Dividend Rate
    Dividend Yield
    1 Year High$11.72
    1 Year Low$2.79
    Open$9.98
    High$10.40
    Low$9.44

    Buy any stock with any amount of money.

    Download the App
    Download the app